首页 | 本学科首页   官方微博 | 高级检索  
检索        

未折叠蛋白反应参与胰腺癌化疗耐药研究进展
引用本文:陈浩,朱克祥.未折叠蛋白反应参与胰腺癌化疗耐药研究进展[J].医学研究杂志,2024,53(1):5-8, 12.
作者姓名:陈浩  朱克祥
作者单位:兰州大学第一临床医学院 730000
基金项目:国家自然科学基金资助项目(81960516)
摘    要:化疗耐药是导致胰腺癌预后不良的重要因素,耐药形成受多种因素调控,其中包括内质网应激(endoplasmic reticulum stress,ERS)状态下的未折叠蛋白反应(unfolded protein response, UPR)。UPR通过参与化疗药物外排、自噬、上皮-间充质转化和肿瘤干细胞形成等过程, 最终导致胰腺癌耐药。本文综述了近年来未折叠蛋白反应在胰腺癌耐药过程中的作用机制,旨在为改善胰腺癌不良预后提供参考。

关 键 词:胰腺癌  耐药  未折叠蛋白反应  内质网应激
收稿时间:2022/11/7 0:00:00
修稿时间:2022/11/10 0:00:00

Study on the Policy and Application of Cloud Migration in Chinese Hospitals
Abstract:Objective/Significance To summarize the relevant policies, practical applications and promotion effects of hospital information systems (HIS) on the cloud in China, to analyze national policy orientation and application status, so as to put forward reasonable proposals on the next action and promotion strategy.Method/Process Relevant policy documents and applications of HIS on the cloud are retrieved from national and provincial government websites in China,and the policy development rules and opportunities and challenges faced are summarized.Relevant articles published from 2010 to 2023 are searched on CNKI to summarize the concrete practice of HIS on the cloud.Result/Conclusion It is suggested that hospitals with existing conditions can make full use of the current national policy dividend and actual business expansion needs to migrate to the cloud as soon as possible, and relevant departments should also issue more targeted development strategies and supporting implementation guidelines to specifically guide hospitals to migrate to the cloud scientifically, effectively and safely, so as to accelerate the generation of new forms of medical industry and fully meet the needs of public health care in the new era.
Keywords:
点击此处可从《医学研究杂志》浏览原始摘要信息
点击此处可从《医学研究杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号